SavedAdd your journal

Journals / İstanbul Medical Journal / 2014 / Cilt: 15 - Sayı: 3

Cost-effectiveness of Diagnostic Strategies in Guidance of Treatment Strategies in Stable Coronary Artery Disease: "Myocardial Perfusion Scan as a Gatekeeper"

Kararlı Koroner Arter Hastalığında Tedavi Stratejileri Kılavuzluğunda Tanı Stratejilerinin Maliyet Etkinliği: "Bir Öncü-eleyici Test Olarak Miyokard Perfüzyon Sintigrafisi"

Coşkun AK
Cengiz TAŞÇI
Pages
145–153
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, the prognostic outcomes and cost-effectiveness of the initial diagnostic strategies in stable CAD were assessed together with new insights in treatment strategies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite its younger population, coronary artery disease (CAD) is the lead- ing cause of death in Turkey, as it is in Europe and the United States.
📊
Key Findings & Data:The prevalence of CAD in our country increases steadily.
💡
Conclusion & Impact:For this reason, the prognostic outcomes and cost-effectiveness of the initial diagnostic strategies in stable CAD were assessed together with new insights in treatment strategies
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Despite its younger population, coronary artery disease (CAD) is the lead- ing cause of death in Turkey, as it is in Europe and the United States. The prevalence of CAD in our country increases steadily. So, the healthcare sys- tem must take care of the economic consequences of the disease as much as its clinical results. This overview was written to enable such an evalu- ation. For this reason, the prognostic outcomes and cost-effectiveness of the initial diagnostic strategies in stable CAD were assessed together with new insights in treatment strategies

Özet

Genç nüfusuna rağmen AB ve ABD'de olduğu gibi ülkemizde de koroner arter hastalığı (KAH) önde gelen ölüm sebebidir. Ayrıca ülkemizde KAH prevalansı giderek artmaktadır. Bu nedenle sağlık sisteminin hem klinik sonuçları, hem de sağlık ekonomisi açısından KAH ile daha yakından ilgilenmesi zorunluluk kazanmaktadır. Bu çalışma böyle bir değerlendirmeye olanak sağlamak üzere derlenmiştir. Bu amaçla kararlı KAH hastalarında ilk adım tanı stratejilerinin klinik ve maliyet etkinlikleri, güncel tedavi stratejileri ile birlikte ele alınmıştır.

🔖

Cite This Article

AK, C., TAŞÇI, C. (2022). Cost-effectiveness of Diagnostic Strategies in Guidance of Treatment Strategies in Stable Coronary Artery Disease: "Myocardial Perfusion Scan as a Gatekeeper". İstanbul Medical Journal, Cilt: 15 - Sayı: 3, 145–153. https://ajindex.com/articles/552192

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57. [CrossRef] Sans S1, Kesteloot H, Kromhout D. The burden of cardiovascular dise- ases mortality in Europe. Task Force of the European Society of Cardi- ology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-48. [CrossRef] Ünüvar N, Mollahaliloğlu S, Yardım N. TC Sağlık Bakanlığı adına Refik Saydam Hıfzıssıhha Merkezi, Hıfzıssıhha Mektebi Müdürlüğü. Türkiye Hastalık Yükü Çalışması 2004. 1. basım. Sağlık Bakanlığı Yayın No: 701. Ankara, 2007; 4-8. WHO. The Global Burden of Disease: 2004
  2. Update. Switzerland, WHO Press 2008, 1-49.
  3. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27: 1610-9. [CrossRef] Onat A, Hergenc G, Can G, Yüksel H, Sansoy V, Erginel-Ünaltuna N ve ark. TEKHARF 2009: Türk Halkının Kusurlu Kalp Sağlığı Sırrına Işık, Tıbba Önemli Katkı. Onat A, editor. Erişkinlerimizde Kalp Hastalıkları Prevalansı, Yeni Koroner Olaylar ve Kalpten Ölüm Sıklığı. 1. Baskı. İs- tanbul: Figür Grafik ve Matbaacılık; 2009.p.19-24. WHO/Europe. 'European health for all database (HFA-DB)'. http:// data.euro.who.int/hfadb/ (1970-2010, Last Access; October 2013).
  4. Taşçı C, Özçelik N. An Overview on Coronary Heart Disease (A Com- parative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies. Mol Imaging Radionucl Ther 2011; 20: 75-93. [CrossRef] Simoons ML, Windecker S. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J 2010; 31: 530-41. [CrossRef] Fernandez SF, Boden WE. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials. Curr Atheroscler Rep 2010; 12: 423-31. [CrossRef] Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003. [CrossRef] Gibbons RJ. Noninvasive diagnosis and prognosis assessment in chro- nic coronary artery disease: stress testing with and without imaging perspective. Circ Cardiovasc Imaging 2008; 1: 257-69. [CrossRef] Shaw LJ, Narula J. Risk Assessment and Predict